Mehmood Khan

2.6k total citations · 1 hit paper
40 papers, 1.9k citations indexed

About

Mehmood Khan is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Mehmood Khan has authored 40 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Molecular Biology and 12 papers in Surgery. Recurrent topics in Mehmood Khan's work include Diabetes Treatment and Management (9 papers), Peroxisome Proliferator-Activated Receptors (8 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Mehmood Khan is often cited by papers focused on Diabetes Treatment and Management (9 papers), Peroxisome Proliferator-Activated Receptors (8 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Mehmood Khan collaborates with scholars based in United States, Pakistan and Bangladesh. Mehmood Khan's co-authors include John V. St. Peter, David M. Kendall, Anthony J. Zagar, John B. Buse, Mark A. Deeg, Ronald Goldberg, Scott J. Jacober, Meng H. Tan, Jay L. Xue and Alfonso T. Perez and has published in prestigious journals such as New England Journal of Medicine, Diabetes Care and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Mehmood Khan

39 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

2005 626 citations Ronald Goldberg, Mehmood Khan et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mehmood Khan United States	20	975	834	506	246	238	40	1.9k
Valdis Pīrāgs Latvia	22	1.0k 1.1×	877 1.1×	527 1.0×	269 1.1×	94 0.4×	86	2.1k
Sibilla Salvadeo Italy	24	907 0.9×	618 0.7×	288 0.6×	234 1.0×	222 0.9×	51	1.6k
Hideaki Jinnouchi Japan	26	1.1k 1.1×	768 0.9×	550 1.1×	262 1.1×	127 0.5×	81	2.3k
Maria Luiza Caramori United States	16	852 0.9×	555 0.7×	368 0.7×	264 1.1×	137 0.6×	32	2.7k
Michele T. Rooney United States	10	722 0.7×	538 0.6×	317 0.6×	206 0.8×	106 0.4×	18	2.1k
Silvia Pinach Italy	24	549 0.6×	620 0.7×	389 0.8×	222 0.9×	295 1.2×	44	1.9k
Gianluca Bardini Italy	20	1.1k 1.1×	491 0.6×	432 0.9×	237 1.0×	112 0.5×	40	1.6k
Mario N. Piccinni Italy	21	846 0.9×	573 0.7×	322 0.6×	150 0.6×	188 0.8×	31	1.4k
Kum Hyun Han South Korea	27	376 0.4×	545 0.7×	315 0.6×	247 1.0×	194 0.8×	50	2.0k
Stanley S. Schwartz United States	21	1.4k 1.5×	671 0.8×	573 1.1×	337 1.4×	184 0.8×	64	2.3k

Countries citing papers authored by Mehmood Khan

Since Specialization

Citations

This map shows the geographic impact of Mehmood Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehmood Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehmood Khan more than expected).

Fields of papers citing papers by Mehmood Khan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehmood Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehmood Khan. The network helps show where Mehmood Khan may publish in the future.

Co-authorship network of co-authors of Mehmood Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Mehmood Khan. A scholar is included among the top collaborators of Mehmood Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehmood Khan. Mehmood Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hashmi, Atif A, Zubaida Fida Hussain, Muhammad Irfan, et al.. (2017). Latent membrane protein 1 (LMP1) expression in Hodgkin lymphoma and its correlation with clinical and histologic parameters. World Journal of Surgical Oncology. 15(1). 89–89. 13 indexed citations

Hashmi, Atif A, Rabia Ali, Zubaida Fida Hussain, et al.. (2017). Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters. World Journal of Surgical Oncology. 15(1). 116–116. 26 indexed citations

Beg, Mirza Arshad, et al.. (2017). Arranging blood for elective thyroid surgeries: dilemma continues in the developing world. BMC Research Notes. 10(1). 49–49. 6 indexed citations

Hashmi, Atif A, et al.. (2016). Mutiple keratocystic odontogenic tumors (KCOT) in a patient with Gorlin syndrome: a case report with late presentation and absence of skin manifestations. BMC Research Notes. 9(1). 357–357. 4 indexed citations

Hashmi, Atif A, Samreen Naz, Muhammad Muzzammil Edhi, et al.. (2016). Accuracy of intraoperative frozen section for the evaluation of ovarian neoplasms: an institutional experience. World Journal of Surgical Oncology. 14(1). 91–91. 26 indexed citations

Hashmi, Atif A, Zubaida Fida Hussain, Muhammad Muzzammil Edhi, et al.. (2016). Clinicopathologic features of ovarian neoplasms with emphasis on borderline ovarian tumors: an institutional perspective. BMC Research Notes. 9(1). 205–205. 8 indexed citations

Hashmi, Atif A, Amna Khurshid, Naveen Faridi, Muhammad Muzzammil Edhi, & Mehmood Khan. (2015). A large mediastinal benign myoepithelioma effacing the entire hemithorax: case report with literature review. Diagnostic Pathology. 10(1). 100–100. 4 indexed citations

Siddiqui, Faisal, et al.. (2015). Effect of bupivacaine soaked gauze in postoperative pain relief in laparoscopic cholecystectomy: a prospective observational controlled trial in 120 patients. Patient Safety in Surgery. 9(1). 31–31. 7 indexed citations

Naz, Samreen, Atif A Hashmi, Amna Khurshid, et al.. (2015). Diagnostic role of fine needle aspiration cytology (FNAC) in the evaluation of salivary gland swelling: an institutional experience. BMC Research Notes. 8(1). 101–101. 38 indexed citations

10.

Hashmi, Atif A, et al.. (2014). Clinicopathologic features of triple negative breast cancers: an experience from Pakistan. Diagnostic Pathology. 9(1). 43–43. 42 indexed citations

11.

Gravina, Stephen A., et al.. (2013). Human Biology of Taste. Annals of Saudi Medicine. 33(3). 217–222. 53 indexed citations

12.

Berhanu, Paulos, Mark Kipnes, Mehmood Khan, et al.. (2006). Effects of pioglitazone on lipid and lipoprotein profiles in patients with type 2 diabetes and dyslipidaemia after treatment conversion from rosiglitazone while continuing stable statin therapy. Diabetes and Vascular Disease Research. 3(1). 39–44. 50 indexed citations

13.

Khan, Mehmood, Alfonso García‐Pérez, Ronald Goldberg, Robert G. Spanheimer, & Scott J. Jacober. (2006). Abstract #277: Subanalysis of the Comparative Effects of Pioglitazone and Rosiglitazone on Markers of Diabetic Dyslipidemia in Elderly Patients With Type 2 Diabetes and Dyslipidemia. Endocrine Practice. 12. 18–19. 2 indexed citations

14.

Khan, Mehmood, et al.. (2005). Abstract #886: Effects of Pioglitazone on Lipid Subparticle Profiles in Patients with Metformin or Insulin Therapy: A Double-Blind, Randomized Study of Pioglitazone Versus Placebo in Reducing or Eliminating Insulin Requirements. Endocrine Practice. 11. 29–29. 1 indexed citations

15.

Rajagopalan, Rukmini, Alfonso Pérez, Zhan Ye, Mehmood Khan, & Frederick T. Murray. (2004). Pioglitazone is Effective Therapy for Elderly Patients with Type 2 Diabetes Mellitus. Drugs & Aging. 21(4). 259–271. 23 indexed citations

16.

Diani, A. R., Geri A. Sawada, B. M. Wyse, Frederick T. Murray, & Mehmood Khan. (2004). Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes. American Journal of Physiology-Endocrinology and Metabolism. 286(1). E116–E122. 78 indexed citations

17.

Khan, Mehmood, John V. St. Peter, & Jay L. Xue. (2002). A Prospective, Randomized Comparison of the Metabolic Effects of Pioglitazone or Rosiglitazone in Patients With Type 2 Diabetes Who Were Previously Treated With Troglitazone. Diabetes Care. 25(4). 708–711. 205 indexed citations

18.

Peter, John V. St., et al.. (2001). Factors Associated with the Risk of Liver Enzyme Elevation in Patients with Type 2 Diabetes Treated with a Thiazolidinedione. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(2). 183–188. 5 indexed citations

19.

Khan, Mehmood, Charles A. Herzog, John V. St. Peter, et al.. (1999). The Prevalence of Cardiac Valvular Insufficiency Assessed by Transthoracic Echocardiography in Obese Patients Treated with Appetitie-Suppressant Drugs. Survey of Anesthesiology. 43(3). 186–187. 19 indexed citations

20.

Khan, Mehmood, Charles A. Herzog, John V. St. Peter, et al.. (1998). The Prevalence of Cardiac Valvular Insufficiency Assessed by Transthoracic Echocardiography in Obese Patients Treated with Appetite-Suppressant Drugs. New England Journal of Medicine. 339(11). 713–718. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact